< Back | |
10 Dec 2014 | |
Cipla Ltd has informed BSE that Meditab Holdings Limited, Mauritius, a wholly owned subsidiary of the Company, has entered into a definitive agreement to sell its entire 48.22% equity interest in Jiangsu Cdymax Pharmaceuticals Co. Ltd., China (Jiangsu) to an affiliate of one of the other shareholders of Jiangsu, for a total consideration of USD 18.5 million.<BR><BR>The closing of the transaction is subject to receipt of applicable regulatory approvals in China. | |
View all announcements for CIPLA LTD. | Source: BSE India |